Stockreport

Calliditas Announces Positive NefIgArd Open Label Extension Results [Yahoo! Finance]

Calliditas Therapeutics AB - American Depositary Shares  (CALT) 
PDF the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protei [Read more]